Drug intelligence / Profile preview

Toutongting

Development stage: Unknown
Lead developer: Jilin Huinan Huayi Pharmaceutical
Administration: Oral

Overview

Toutongting is a Traditional Chinese Medicine (TCM) formulation primarily used for the treatment of various types of headaches, including migraines and tension-type headaches. It typically consists of a blend of herbal extracts such as *Ligusticum chuanxiong*, *Angelica dahurica*, and *Pueraria lobata*. The mechanism involves promoting blood circulation, dispelling wind, and relieving pain. It is widely manufactured by several pharmaceutical companies in China, such as Jilin Huinan Huayi Pharmaceutical, and is regulated as a patent medicine by the National Medical Products Administration (NMPA).

Brand names: Toutongting
Other names: Tou-tong-tingToutongting capsuleToutongting jiaonang

Beyond the preview

Go deeper on Toutongting.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Toutongting.

Explore the full profile